← Dashboard
Oct 24, 2026 02:55 PM ET
Signal
FDA/Bio
Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial - Reuters
J&J's prostate cancer drug shrank tumors in an early-stage trial, per Reuters.
What changed
J&J's prostate cancer drug shrank tumors in an early-stage trial, per Reuters.
Why it matters
J&J's prostate cancer drug shrank tumors in an early-stage trial, per Reuters. — impact context not separately stored; see What changed.
Sources
gnews
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →